logo

Brainstorm Cell Therapeutics, Inc. (BCLI) Stock: Exploring a Year of Highs, Lows, and Trading Volume

OPEN Stock

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Brainstorm Cell Therapeutics, Inc.’s current trading price is -78.62% away from its 52-week high, while its distance from the 52-week low is 452.16%. The stock’s price range over this period has fluctuated between $0.13 and $3.46. The company, operating within the financial sector, had a trading volume of approximately 1.44 million for the day, which was noticeably higher than the average daily share volume of 0.97 million over the last 3 months.

Brainstorm Cell Therapeutics, Inc. experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $3.46 on 04/03/23, while the lowest price for the same period was registered at $0.13 on 10/31/23.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Brainstorm Cell Therapeutics, Inc. (BCLI) has experienced a quarterly rise of 180.05% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 36.24M.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.3144, with a change in price of +0.5689. Similarly, Brainstorm Cell Therapeutics, Inc. recorded 2,048,518 in trading volume during the last 100 days, posting a change of +332.69%.

BCLI Stock Stochastic Average

Today’s raw stochastic average for Brainstorm Cell Therapeutics, Inc. over the last 50 days is 89.90%.This indicates a increase from the raw stochastic average of the past 20 days, which was 89.90%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 67.55% and 63.64%, respectively.

BCLI Stock Price Performance Analysis

Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. Year to date metric has recorded a gain of 171.03%.However, over the last six months, we can see a weaker performance of 261.10%. Over the last 30 days, the price of BCLI has fallen by 101.61%. And in the last five days, it has surged by 29.81%.